GARS Innovative New Precision Genetic Risk Tool Helps Doctors Better Predict And Treat Addiction

Share Article

Geneus Health is proud to announce the official launch of the Genetic Addiction Risk Score (GARS™) test, a new and innovative genetic addiction risk assessment tool. Geneus Health is the only company solely focused on genetic addiction risk and management.

News Image
The GARS™ genetic addiction testing platform is backed by over forty-years of science, experiments, and studies conducted by Dr. Kenneth Blum, co-discoverer of the first known addiction gene.

Imagine if you could know if you or a loved one carries the potential for a catastrophic or life-changing health crisis. How would that information impact your lifestyle and the healthcare choices you make in the future?

Geneus Health is proud to announce the official launch of the Genetic Addiction Risk Score (GARS™) test, a new and innovative genetic addiction risk assessment tool. Geneus Health is the only company solely focused on genetic addiction risk and management. Through a simple noninvasive cheek swab, GARS™ identifies and quantifies specific genetic markers that are known to be associated with addiction. The GARS™ report not only outlines the individual’s genetic risk or vulnerability to alcohol and/or drug addiction, but also non-substance addictive behaviors including gambling, sex, and online gaming.

The GARS™ platform is backed by over forty-years of science, experiments, and studies conducted by Dr. Kenneth Blum, co-discoverer of the first known addiction gene. Blum’s persistence in connecting addiction to genetics has given us a diagnostic that allows us to understand our potential risk. This is particularly important when considering the raging drug epidemic we are faced with today.

The GARS™ test will play a vital role for:

  • People currently going through addiction treatment or are in recovery
  • Prevention, to better guide doctors on how to more appropriately prescribe narcotics (opioids)
  • People who just want to know themselves better, so they can live a healthier lifestyle

CEO Justin Jones states “it is very important to understand that genetics is only 50% of the equation when it comes to addiction. “At risk” environments make up the other half. If people know which “at risk” environments to avoid, then there is a lower risk of triggering addictive behaviors.” If people can be empowered with this valuable information, then the GARS™ could be one of the most significant technologies introduced in decades to help prevent and battle addiction.

The GARS™ test can be ordered online at http://www.GeneusHealth.com, or though a certified Geneus Health partner.

ABOUT GENEUS HEALTH

Geneus Health is a cutting edge genetic testing company that is revolutionizing addiction management. This is being accomplished through our disruptive “Precision Addiction Management” platform.

For more information or to schedule interviews with Dr. Blum or Erin Gallagher please contact:
Omni Publicity
Joe Ullrich

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Joe Ullrich
Visit website